First Coronavirus Vaccine Could Come to Market Early Next Year

at 10:00 AM
Save Article

Failed to save article

Please try again

People walk by the Pfizer world headquarters in New York on November 9, 2020. (KENA BETANCUR/AFP via Getty Images)

Early tests show that a coronavirus vaccine from drugmakers Pfizer and BioNTech could be 90 percent effective at preventing COVID-19, a disease that has now infected more than 10 million Americans and killed more than a million. While those results look promising, experts say the production and distribution of the vaccine -- which needs to be kept at negative 80 degrees Celsius -- will be complicated to say the least. Other challenges include convincing enough Americans to take the vaccine amid a climate of distrust and misinformation. Meanwhile, other drugmakers are also pushing to bring vaccines to the market. We’ll talk about the status of a coronavirus vaccine.

Guests:

Dr. Peter Chin-Hong, Infectious Disease Specialist, UCSF Medical Center

Meg Tirrell, senior health and science reporter, CNBC

Sponsored